Isoprinosine

Inosine Pranobex, the active ingredient in Isoprinosine, is a antiviral, immunostimulant presented as an oral formulation for systemic use. It is employed to manage viral infections and to support immune function in selected patient groups.

GNH USA supplies Isoprinosine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprinosine acts on viral pathogens and modulates immune responses, making it useful for several infectious and immunodeficiency conditions. - Herpes simplex infections: reduces lesion duration and viral shedding. - Human papillomavirus (HPV) infections: assists clearance of cutaneous lesions. - Subacute sclerosing panencephalitis: provides antiviral support in chronic measles complications. - Influenza: shortens symptom course and limits viral replication. - Immunodeficiency support: enhances host defenses in patients with weakened immunity.

Adverse reactions may occur with oral Inosine Pranobex.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Elevated liver enzymes: mild, reversible increase in hepatic transaminases. - Skin rash: erythematous or maculopapular eruptions.

Serious or Rare Side Effects: - Severe hypersensitivity: anaphylaxis or angioedema requiring immediate medical attention. - Hematologic abnormalities: rare cases of leukopenia or thrombocytopenia. - Hepatotoxicity: significant liver injury manifested by jaundice or marked enzyme elevation.

Use Isoprinosine only under medical supervision, considering individual health status and concomitant conditions. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; consider discontinuation during lactation. - Liver disease: monitor hepatic function regularly. - Renal impairment: dose adjustment may be required based on clinical judgment. - Drug interactions: review concomitant medications for potential conflicts. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Inosine Pranobex may interact with other agents that affect immune function or hepatic metabolism.

Major Interactions (Avoid): - Immunosuppressants (e.g., cyclosporine, tacrolimus): may counteract immunostimulatory effect. - Hepatotoxic drugs (e.g., high‑dose acetaminophen): increase risk of liver injury.

Moderate Interactions (Monitor Closely): - Antiviral agents (e.g., acyclovir): potential additive antiviral activity. - Anticoagulants (e.g., warfarin): monitor coagulation parameters. - Corticosteroids: may alter immune response dynamics.